Previous 10 | Next 10 |
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is focused on tobacco harm reduction, Very Low Nicotine Content tobacco and hemp/cannabis research, announced today that the Company filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019...
The summer of 2019 has not been very kind to the cannabis sector. In fact, if ever there was a time that the allure of cannabis investing was tested, the last three months were it. But now there are certain marijuana stocks to watch moving forward. Because a sector-wide downturn isn...
XXII stock enjoyed a slight rise on Tuesday after announcing Clifford B. Fleet as the Company’s President and CEO. This follows on from 22nd Century Group (NYSE:XXII) hitting a 52-week low last week. Mr. Fleet previously held the position of strategic adviser to the compa...
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced today that the Company has appointed Clifford B. Fleet to serve as the Company ...
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced today that the Company will provide a business update for investors on a conference...
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced today that President and Chief Executive Officer Henry Sicignano III has resigned f...
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a world leader in tobacco harm reduction, announced today that the U.S. Food and Drug Administration (FDA) accepted and filed for substantive scientific review the Company’s Modified Risk Tobacco ...
FDA enjoys broad consumer support to dramatically lower nicotine in cigarettes 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a world leader in tobacco harm reduction, announced today the publication of a report by the Centers for Disease Con...
Investing in penny stocks can be scary. Of course, these investments can end up being worth it, with the possibility of investors repeating enormous gains; but it’s usually a rollercoaster of a journey to get to that point. That’s especially the case with cannabis penny stoc...
22nd Century Group ( XXII -1.7% ) announces the appointment of Michael Zercher as the company's chief operating officer. More news on: 22nd Century Group, Inc., Consumer stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...